Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine‐homocysteine mixed disulphide

European Journal of Clinical Investigation - Tập 9 Số 4 - Trang 301-307 - 1979
D. E. L. Wilcken1, Vatsala Gupta1
1Department of Medicine, Prince Henry Hospital, Little Bay (Sydney), New South Wales, Australia

Tóm tắt

Abstract. We measured plasma sulphur amino acids in twenty‐two patients with chronic renal failure and compared the findings with those obtained in twenty‐two normal subjects. In fasting blood (08.00 hours) cysteine‐homocysteine mixed disulphide was significantly increased in the renal patients, mean values (± SD) being 8.2 ± 3.4 and 3.1 ± 1.0 μmol/l respectively (P < 0.001). The increase was positively correlated with reduced renal function, as assessed by serum creatinine (r= 0.62; P < 0.01). Homocystine was detected in nineteen patients, the mean concentration (± SD) being 1.7 ± 0.6 μmol/l; it was not found in any normal subject. Methionine levels were not different but there were significant increases in cystine (P < 0.001) and taurine (P < 0.05) in the patients. Similar values for these amino acids were found in a second blood sample drawn at 16.00 hours. Changes in the other neutral and acidic amino acids measured were in agreement with those reported in chronic azotaemia. We concluded that plasma levels of all the principal sulphur amino acids except methionine are elevated in chronic renal failure emphasizing the importance of the kidney in sulphur excretion. Prolonged accumulation of homocysteine and cysteine‐homocysteine mixed disulphide may be relevant to the development of accelerated vascular disease in patients with chronic renal failure by producing endothelial damage.

Từ khóa


Tài liệu tham khảo

Ibels L.S., 1977, Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis, Q J Med N.S., 46, 197

10.1159/000180624

10.1136/bmj.3.5930.552

Winchester J.F., 1977, Thromboembolism: A New Approach to Therapy, 83

10.1056/NEJM197608122950707

10.1056/NEJM197409122911101

10.1172/JCI108520

10.1111/j.1365-2362.1978.tb00853.x

10.1016/0009-8981(76)90354-5

10.1016/0009-8981(72)90401-9

10.1016/0009-8981(71)90433-5

Bergstrom J., 1978, Intracellular free amino acids in muscle tissue of patients with chronic uraemia: effect of peritoneal dialysis and infusion of essential amino acids, Clin Sci Mol Med, 54, 51

Kopple J.D., 1974, Nitrogen balance and plasma amino acid levels in uremic patients fed an essential amino acid diet, Am J Clin Nutr, 27, 806, 10.1093/ajcn/27.8.806

Kopple J.D., 1978, Amino acid and protein metabolism in renal failure, Am J Clin Nutr, 31, 1532, 10.1093/ajcn/31.9.1532

Delaporte C., 1978, Free plasma and muscle amino acids in uremic children, Am J Clin Nutr, 31, 1647, 10.1093/ajcn/31.9.1647

10.1172/JCI108409

Kopple J.D., 1976, Clinical Aspects of Uremia and Dialysis, 241

Awapara J., 1976, Taurine, 1

Harper H.A., 1973, Review of Physiological Chemistry, 416

Spannuth C.L., 1977, Increased plasma clearance of pyridoxal 5'‐phosphate in vitamin B6‐deficient uremic man, J Lab Clin Med, 90, 632

Mudd S.H., 1978, The Metabolic Basis of Inherited Disease, 458

10.1016/0009-8981(67)90005-8

Perry T.L., 1974, Heritable Disorders of Amino Acid Metabolism, 395

10.1172/JCI104186

Jocelyn P.C., 1972, Biochemistry of the SH Group, 122

McKusick V.A., 1972, Heritable Disorders of Connective Tissue., 233

McCully K.S., 1969, Vascular pathology of homocystinemia: implications for the pathogenesis of arteriosclerosis, Am J Pathol, 56, 111

Young G.A., 1973, Impairment of phenylalanine hydroxylation in chronic renal insufficiency, Clin Sci Mol Med, 45, 89

Scriver C.R., 1973, Amino Acid Metabolism and its Disorders, 384